NM_003809.3:c.433C>T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_003809.3(TNFSF12):​c.433C>T​(p.Arg145Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000154 in 1,562,748 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R145H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

TNFSF12
NM_003809.3 missense

Scores

5
9
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 1.45

Publications

3 publications found
Variant links:
Genes affected
TNFSF12 (HGNC:11927): (TNF superfamily member 12) The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is a ligand for the FN14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF, but displays a much wider tissue distribution. This cytokine, which exists in both membrane-bound and secreted forms, can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis. Alternative splicing results in multiple transcript variants. Some transcripts skip the last exon of this gene and continue into the second exon of the neighboring TNFSF13 gene; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13. [provided by RefSeq, Oct 2010]
TNFSF12-TNFSF13 (HGNC:33537): (TNFSF12-TNFSF13 readthrough) This gene encodes a member of the tumor necrosis factor superfamily. It encodes a hybrid protein composed of the cytoplasmic and transmembrane domains of family member 12 fused to the C-terminal domain of family member 13. The hybrid protein is membrane anchored and presents the receptor-binding domain of family member 13 at the cell surface. It stimulates cycling in T- and B-lymphoma cell lines. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High AC in GnomAdExome4 at 20 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNFSF12NM_003809.3 linkc.433C>T p.Arg145Cys missense_variant Exon 6 of 7 ENST00000293825.11 NP_003800.1 O43508-1Q4ACW9
TNFSF12-TNFSF13NM_172089.4 linkc.433C>T p.Arg145Cys missense_variant Exon 6 of 11 NP_742086.1 O43508-2A0A0A6YY99
TNFSF12NR_037146.2 linkn.768C>T non_coding_transcript_exon_variant Exon 7 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNFSF12ENST00000293825.11 linkc.433C>T p.Arg145Cys missense_variant Exon 6 of 7 1 NM_003809.3 ENSP00000293825.6 O43508-1
TNFSF12-TNFSF13ENST00000293826.4 linkc.433C>T p.Arg145Cys missense_variant Exon 6 of 11 1 ENSP00000293826.4 A0A0A6YY99

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152166
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000185
AC:
4
AN:
215790
AF XY:
0.0000345
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000103
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000142
AC:
20
AN:
1410464
Hom.:
0
Cov.:
31
AF XY:
0.0000201
AC XY:
14
AN XY:
695386
show subpopulations
African (AFR)
AF:
0.0000313
AC:
1
AN:
31924
American (AMR)
AF:
0.00
AC:
0
AN:
38068
Ashkenazi Jewish (ASJ)
AF:
0.0000431
AC:
1
AN:
23218
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38944
South Asian (SAS)
AF:
0.000138
AC:
11
AN:
79808
European-Finnish (FIN)
AF:
0.0000192
AC:
1
AN:
52120
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5562
European-Non Finnish (NFE)
AF:
0.00000554
AC:
6
AN:
1082778
Other (OTH)
AF:
0.00
AC:
0
AN:
58042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152284
Hom.:
0
Cov.:
31
AF XY:
0.0000269
AC XY:
2
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41544
American (AMR)
AF:
0.0000654
AC:
1
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000245
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Aug 28, 2018
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Common variable immunodeficiency Uncertain:1
Jul 09, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Experimental studies have shown that this missense change affects TNFSF12 function (PMID: 23493554). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 225690). This missense change has been observed in individual(s) with antibody deficiency (PMID: 23493554). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 145 of the TNFSF12 protein (p.Arg145Cys). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Pathogenic
0.33
D
BayesDel_noAF
Pathogenic
0.24
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.94
D;.
Eigen
Uncertain
0.25
Eigen_PC
Benign
0.22
FATHMM_MKL
Benign
0.59
D
LIST_S2
Uncertain
0.89
D;D
M_CAP
Pathogenic
0.43
D
MetaRNN
Uncertain
0.70
D;D
MetaSVM
Uncertain
0.68
D
MutationAssessor
Uncertain
2.1
M;.
PhyloP100
1.4
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-4.2
D;N
REVEL
Uncertain
0.62
Sift
Uncertain
0.0040
D;D
Sift4G
Uncertain
0.014
D;D
Polyphen
1.0
D;.
Vest4
0.82
MVP
0.44
MPC
1.5
ClinPred
0.69
D
GERP RS
2.2
Varity_R
0.37
gMVP
0.41
Mutation Taster
=5/95
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs540997935; hg19: chr17-7460154; API